- AuthorisedTherapeutic confirmatory (Phase III)
A prospective, randomized, and controlled study comparing two treatment strategies (Dose REduction of Antipsychotics vs. Maintenance treatment) in patients with schizophrenia spectrum disorder after Stratification based on patients’ psychotic PHENotype: a personalized medicine approach
This study compares two ways to treat schizophrenia: either continuing usual medication or carefully reducing it. It aims to see which approach helps patients live better lives by checking their daily function over two years. Researchers hope to find a more personalised treatment.
For: Patient with a diagnosis of schizophrenia spectrum disorder (SSD): schizophrenia · schizophreniform · schizoaffective disorder or brief psychotic episode according to DSM-5France - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2 Open-label, multicenter study to evaluate efficacy and safety of ZN-c3 in Adult Women with Recurrent or Persistent Uterine Serous Carcinoma
This study is testing a new medicine, ZN-c3, for women with a type of womb cancer called uterine serous carcinoma that has come back or is still present. It aims to see how well the medicine works and if it has any side effects.
For: recurrent or persistent uterine serous carcinomaSpain · Italy · France - Ongoing, recruitingTherapeutic use (Phase IV)
Safety and efficacy of olanzapine treatment in psychosis: Effect of genetic and epigenetic factors – covariates of treatment response
This study looks at how a medicine called olanzapine works for people with psychosis. We want to understand if a person's genes or other natural body processes affect how well the treatment works and if they experience side effects. It’s for adults and focuses on how treatment is used in real life.
For: PsychosesCzechia